# Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism

> **NCT02901041** · PHASE3 · COMPLETED · sponsor: **Boston University Charles River Campus** · enrollment: 81 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** Zonisamide
- **BEHAVIORAL:** Take Control
- **DRUG:** Placebo (for Zonisamide)

## Key facts

- **NCT ID:** NCT02901041
- **Lead sponsor:** Boston University Charles River Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-21
- **Primary completion:** 2022-01-04
- **Final completion:** 2022-01-04
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02901041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02901041, "Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02901041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*